Paratek investor relations
Web9 Aug 2024 · Paratek reported net income of $9.7 million, or $0.20 per share, for the second quarter of 2024, compared to a net loss of $23.1 million, or ($0.53) per share, for the same … Web18 Jan 2024 · Investor Contact Information Company Rigel Pharmaceuticals, Inc. 611 Gateway Blvd Suite 900 South San Francisco, CA 94080 Investor Relations Rigel Pharmaceuticals, Inc. [email protected] Transfer Agent EQ Shareowner Services T: 800-401-1957
Paratek investor relations
Did you know?
Web26 Apr 2024 · Domestic investors wishing to participate in the call should dial: 877-300-8521 and international investors should dial: +1-412-317-6026. The conference ID is 10166263. Investors can also...
Web25 Jul 2024 · The audio webcast can be accessed under "Events and Presentations" in the Investor Relations section of the Company's website at www.ParatekPharma.com. Domestic investors wishing to participate in the call should dial 877-300-8521 and international investors should dial +1-412-317-6026. The conference ID is 10169245. Web3 Nov 2024 · Investor Relations: Hans Vitzthum LifeSci Advisors [email protected] Phone: 617-430-7578 Media: Christine Fanelle Scient PR [email protected] Phone: 215-595-5211 Paratek...
Web3 Nov 2024 · Investor Relations: Hans Vitzthum LifeSci Advisors [email protected] Phone: 617-430-7578. Media: Christine Fanelle Scient PR [email protected] Phone: … WebExecutive Chairman, Board of Directors. Evan Loh, M.D. Chief Executive Officer, Director. Adam Woodrow. President and Chief Commercial Officer. William Haskel. Chief Legal …
WebApril 10, 2024. BOSTON, April 10, 2024 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government and military use, today ...
Web7 Apr 2024 · See the latest Paratek Pharmaceuticals Inc stock price (NASDAQ:PRTK), related news, valuation, dividends and more to help you make your investing decisions. moyne river victoriaWebParatek Pharmaceuticals Announces Full-Year 2024 Revenue of $160.3 Million March 8, 2024 Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 16 March 1, 2024 Paratek … moyne houseWebAdam Woodrow President and Chief Commercial Officer William Haskel Chief Legal Officer, General Counsel and Corporate Secretary Randy Brenner Chief Development and … moyne national school longfordWeb9 Aug 2024 · Paratek Pharmaceuticals Announces Total Revenue of $57.5 Million in the Second Quarter 2024 Paratek Pharmaceuticals August 9, 2024, 1:05 PM · 11 min read -- NUZYRA® (omadacycline) Generated Net... moyne templetuohy parishWeb3 Jan 2024 · Paratek Pharmaceuticals' enterprise value of $369 million is less than 2X 2024 sales. ... Our analysts are third party authors that include both professional investors and individual investors who ... moyne roberts walker fireWeb3 Aug 2024 · Investor Relations: Hans Vitzthum LifeSci Advisors [email protected] Phone: 617-430-7578 Media: Christine Fanelle Scient PR [email protected] Phone: … moyness nurseries blairgowrieWebParatek Pharma Email Alerts Investor Relations Investor Overview Corporate Governance Stock Information SEC Filings News Information Request RSS - SEC Filings RSS - Events … moyne shire council port fairy jobs